LSBCF
LakeShore Biopharma Co., Ltd.Company with tickers: LSBCF, LSBWF
CIK
1946399
CUSIP
G9845F208
Shares Outstanding
41,212,693
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | 614,961,584 | CNY | 2025-03-31 | 20-F | 2025-07-31 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | 107,772,147 | CNY | 2025-03-31 | 20-F | 2025-07-31 |
| Gross Profit | 507,189,437 | CNY | 2025-03-31 | 20-F | 2025-07-31 |
| Operating Expenses | 593,481,321 | CNY | 2025-03-31 | 20-F | 2025-07-31 |
| Research & Development | 146,369,093 | CNY | 2025-03-31 | 20-F | 2025-07-31 |
| Operating Income | -86,291,884 | CNY | 2025-03-31 | 20-F | 2025-07-31 |
| Net Income | -99,982,451 | CNY | 2025-03-31 | 20-F | 2025-07-31 |
| EPS (Basic) | $-5.22 | CNY/shares | 2025-03-31 | 20-F | 2025-07-31 |
| EPS (Diluted) | $-5.22 | CNY/shares | 2025-03-31 | 20-F | 2025-07-31 |